You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Understanding Approaches to Care Across the Evolution of Parkinson Disease

  • Authors: Stuart H. Isaacson, MD, FAAN; Daniel E. Kremens, MD, JD, FAAN
  • CME / ABIM MOC / CE Released: 9/14/2022
  • Valid for credit through: 9/14/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for neurologists, primary care practitioners, nurses, nurse practitioners, and physician assistants who treat patients with PD.

The goal of this activity is for learners to be able to better understand their learning needs related to the management of PD, including personalized treatment selection, and the properties and clinical data of emerging agents.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Differentiation of therapies used for the treatment of PD based on the stage of disease
    • Clinical data for investigational therapies for the management of PD


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Stuart H. Isaacson, MD, FAAN

    Director
    Parkinson's Disease and Movement Disorders Center of Boca Raton
    Boca Raton, Florida

    Disclosures

    Stuart H. Isaacson, MD, FAAN, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Acadia Pharmaceuticals; Acorda Therapeutics; Adamas Pharma; Addex Pharmaceuticals Ltd.; AFFiRiS; Alexza Pharmaceuticals; Allergan Inc.; Amneal Pharmaceuticals; Britannia Pharmaceuticals Limited; Cala Health; Cerecor Inc.; Cerevel Therapeutics; Enterin Inc.; GE Healthcare; Global Kinetics Pty Ltd.; Impax Laboratories Inc.; Impel Pharmaceuticals Inc.; Kyowa Kirin; Lundbeck; Merz Pharma; Neurocrine Biosciences; NeuroDerm Ltd.; Pharma Two B Ltd.; Revance Therapeutics Inc.; Roche; Sage Therapeutics; Scion NeuroStim, Inc.; Stoparkinson; Sunovion; Supernus Pharmaceuticals; Teva Pharmaceuticals; UCB
    Speaker or member of speakers bureau for: AbbVie; Acadia Pharmaceuticals; Acorda Therapeutics; Adamas Pharma; Allergan Inc.; Amneal Pharmaceuticals; Kyowa Kirin; Neurocrine Biosciences; Sunovion; Supernus Pharmaceuticals; Teva Pharmaceuticals
    Research funding from: AbbVie; Acadia Pharmaceuticals; Acorda Therapeutics; Adamas Pharma; Addex Pharmaceuticals Ltd.; Amneal Pharmaceuticals; Aptinyx; Axial Therapeutics; BenevolentAI; Biogen; BioVie; Cadent Therapeutics (Novartis); Cala Health; Cerecor Inc.; Cerevel Therapeutics; Eli Lilly and Company; Enterin Inc.; Global Kinetics Pty Ltd.; Global Kinetics Impax Laboratories Inc.;  Intec Pharma Ltd.; Jazz Pharmaceuticals; Kyowa Kirin; Lundbeck; Neuraly; Neurocrine Biosciences; Neuraly; Neurocrine Biosciences; NeuroDerm Ltd.; Novartis; Parkinson Study Group; Pharm Two B Ltd.; Praxis Precision Medicine; Prilenia Therapeutics; Revance Therapeutics Inc.; Roche; Sage Therapeutics; Sanofi; Scion NeuroStim, Inc.; Stoparkinson; Sunovion; Sun Pharmaceutical Industries Ltd.; Supernus Pharmaceuticals; Teva Pharmaceuticals, Theravance; Transposon Therapeutics; UCB

  • Daniel E. Kremens, MD, JD, FAAN

    Associate Professor of Neurology
    Sidney Kimmel Medical College
    Jefferson University
    Philadelphia, Pennsylvania

    Disclosures

    Daniel E. Kremens, MD, JD, FAAN, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Acadia Pharmaceuticals; Acorda Therapeutics; Adamas Pharmaceuticals/Allergan; Amneal Pharmaceuticals; Avion Pharmaceuticals; Brittania Pharmaceuticals Limited; Kyowa Kirin; Merz Pharma; Neurocrine; Sunovion; Supernus Pharmaceuticals; Teva Pharmaceuticals; US WorldMeds
    Speaker or member of speakers bureau for: Acadia Pharmaceuticals; Acorda Therapeutics; Adamas Pharmaceuticals; Amneal Pharmaceuticals; Kyowa Kirin; Neurocrine Biosciences; Sunovion; Supernus Pharmaceuticals; Teva Pharmaceuticals; US WorldMeds
    Research funding from: Revance Therapeutics Inc.; Voyager Therapeutics

Editors

  • Lisette Arnaud-Hevi, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Lisette Arnaud-Hevi, PhD, has disclosed no relevant financial relationships.

  • Chii Shyang Fong, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Chii Shyang Fong, PhD, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Understanding Approaches to Care Across the Evolution of Parkinson Disease

Authors: Stuart H. Isaacson, MD, FAAN; Daniel E. Kremens, MD, JD, FAANFaculty and Disclosures

CME / ABIM MOC / CE Released: 9/14/2022

Valid for credit through: 9/14/2023

processing....